Molybdenum-99 Market Outlook

According to FMI projection, the molybdenum-99 market could reach a value of US$ 7.28 billion. With a forecast market size of US$ 4.48 billion in 2023, it continues to be one of the radioisotopes that are most frequently utilized in nuclear diagnostic medical operations.

In response to the need for molybdenum-99 to visualize the structure and function of a tissue, organ, bone, or system within the body, a CAGR of 5.0% is projected by 2033. The global Y-o-Y growth for the molybdenum-99 is currently estimated at a little below 5%. However, recently procuring 99Mo has become increasingly difficult.

Various factors are responsible for this, including the shutting down of some nuclear reactors and uncertainties pertaining to reliable operating conditions. Nonetheless, increasing investment in production infrastructure and recent approvals of 99Mo and products derived from it offers substantial economic incentives to the market players.

Innovations are on the cards. However, any new processes with possibilities of influencing product quality in comparison to the existing counterparts must be licensed and demonstrated to realize their market potential.

Attributes Details
Molybdenum-99 Market CAGR (2023 to 2033) 5.0%
Molybdenum-99 Market Size (2023) US$ 4.48 billion
Molybdenum-99 Market Size (2033) US$ 7.28 billion

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Rising Use of Radiotherapy: A Ground-breaking Strategy

The rising penetration of radio-therapeutics is expected to be the chief driver of the global market. Radiotherapeutics is already touted as the next wave in medicine, accounting for nearly 13% of the nuclear medicine market.

As a result of the increasing incidence of prostate and bone cancers, the demand for effective treatment and innovation in medicine is at an all-time high. This is also the primary reason driving investment in radio therapeutics, which has augured well for the molybdenum-99 sector.

Studies suggest that prostate cancer is the second-leading cause of cancer-related deaths in the United States. Despite a significant reduction in fatality in the last couple of years, the disease has continued to cost precious human lives despite advancements in screening methods and treatment.

Penetration of radio-therapeutics is therefore considered a path-breaking move in the cancer diagnostic market. The launch of molybdenum-99 for the treatment of bone and prostate cancer is therefore considered an indispensable move in the medical world.

In the coming years, greater discoveries are on the card, especially as leading players continue investing in advancements. For instance, the demand for effective treatment of tumors impelled the launch of novel radiotherapeutics by GE Healthcare.

How Does the Future Forecast Compare to Past Sales of Molybdenum-99?

Molybdenum-99 usage in nuclear power plants is predicted to increase, along with expanding interest in nuclear energy, and the CAGR remains steady, which is 5% for both time periods. In 2022, the market had a valuation of US$ 4.25 billion.

This is primarily attributed to the need for capacity expansion. While the current supply of 99Mo is considered sufficient to meet global demand, changing the supply chain might result in severe shortages. This can adversely impact the delivery of medical care.

Technetium-99m obtained from 99Mo is one of the primary isotopes used in radionuclide medical imaging. It helps in noninvasively evaluating regional metabolic and psychological processes, such as cardiac blood flow, to localize the affected tissue or organ.

During the forecast period, the market is anticipated to be driven by increased demand for molybdenum-99 generators from nations in the Asia Pacific region and an increase in the number of nuclear medicine facilities. As a result, the molybdenum 99 generator market is also expanding significantly. Despite this, a number of initiatives lead the market to make an absolute dollar opportunity of US$ 253 million during the forecast period. Such initiatives are:

  • Creating new techniques for nuclear reactors to produce molybdenum-99.
  • The expansion of molybdenum-99's accessibility and cost for use in medical imaging.
  • Creating radiopharmaceuticals based on molybdenum-99 for medical imaging.
  • Developing molybdenum-99-based radiopharmaceuticals for cancer treatment.
  • Developing technologies for recycling and reusing molybdenum-99
  • Developing new methods for safely disposing of molybdenum-99.
  • Investigating the environmental impacts of molybdenum-99 production.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Market Dynamics

Use of Molybdenum-99 in Managing Non-communicable Diseases

The demand for molybdenum-99 is rising in response to the increasing incidence of various non-communicable diseases, such as cancer and cardiovascular ailments.

As opposed to communicable diseases witnessed in underdeveloped countries, communicable diseases are primarily byproducts of an aging population, unhealthy and stressful life, and increasing life expectancy. Treatment of non-communicable diseases is often time-consuming and very complicated. A delay in diagnosis can further complicate a patient’s condition.

As a result of these factors, radio-therapeutics are increasingly adopted. Investment, too, is on the cards, especially since healthcare institutions are looking at offering improved patient care through precise diagnosis and accurate treatment.

Social and economic transformation in high-potential pockets has been creating a strong foundation for healthcare developments to happen. Improvement in living standards and per-capita income has made people more willing to spend on advanced treatment, creating a conducive environment for the growth of the 99Mo market.

Demand for molybdenum supplements has increased as a result of increased consumer health consciousness and growing awareness of healthy living. Molybdenum supplements market share in the molybdenum-99 market is projected to be between 10% and 15%.

What Impedes the Molybdenum-99 Industry?

The availability of technetium-99m or 99mTc is dependent on the production and supply of 99Mo from a limited number of nuclear reactors located around the world. Leading ones are close to shutting down, which has been leading to production disruption.

The looming closure of aged reactors or extended shutdowns for planned and unplanned maintenance works have been disrupting the market’s supply chain for the last couple of years.

With this, the demand for alternative imaging modalities has gained momentum, creating significant bottlenecks for the market. As a result of the anticipated shortage in the near future, healthcare institutions are shifting to PET, SPECT, and other imaging modalities, denting future prospects for the market.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Comparative View of Molybdenum-99 Market

Molybdenum-99 Market:

Attributes Molybdenum-99 Market
CAGR (2023 to 2033) 5.0%
Market Value (2033) US$ 7.28 billion
Growth Factor Rising penetration of radiotherapy
Opportunity Mo-99 technology aims at automation
Key Trends Higher investment in the healthcare industry

Molybdenum Market:

Attributes Molybdenum Market
CAGR (2023 to 2033) 4.7%
Market Value (2033) US$ 500 billion
Growth Factor Applications in multiple industries like aerospace, medical, energy, and others
Opportunity Expanding need for its alloy in electronics
Key Trends High focus on recycling processes

Molybdenum Disilicide Market:

Attributes Molybdenum Disilicide Market
CAGR (2023 to 2033) 7.2%
Market Value (2033) US$ 9.11 billion
Growth Factor Surging utilization in production of ceramics, electronics.
Opportunity Increasing use of innovative steel components
Key Trends Existence of a cement production industry that is well-established in different regions

Regional Analysis

A large share of the global supply of molybdenum-99 is derived from irradiating targets, which is a solid plates containing aluminum-clad uranium found across seven reactors located in Canada, Australia, Europe, and South Africa.

Country United States
Market CAGR (2017 to 2022) 4.9%
Absolute Dollar Growth US$ 106.5 million
Country China
Market CAGR (2017 to 2022) 6.9%
Absolute Dollar Growth US$ 10.6 million
Country Canada
Market CAGR (2017 to 2022) 5.8%
Absolute Dollar Growth US$ 13.8 million
Country Germany
Market CAGR (2017 to 2022) 5.0%
Absolute Dollar Growth US$ 9.2 million
Country United Kingdom
Market CAGR (2017 to 2022) 4.9%
Absolute Dollar Growth US$ 8 million

United States Overcoming the Supply Shortage of Molybdenum-99

Future Market Insights (FMI) finds that the capacity of supply has been significantly affected since Canada stopped production towards the end of October 2016. Current efforts are therefore dedicated to increasing the supply by expanding existing production overseas.

  • As the United States is likely to face serious shortages due to limited supply from Canada, efforts are now being dedicated to the expansion of production in overseas locations.
  • There is also considerable focus on initiating domestic production by methods not requiring highly enriched uranium. Various leading institutions are determining strategic moves to fill the gap in the existing supply chain. Further delays in additional supplies of 99Mo can expose the market to the risk of substantial shortage.

This issue is solved by the presence of a sophisticated healthcare network, constituting hospitals and diagnostic centers with state-of-the-art infrastructure that has been of support as well. The United States is likely to dominate the market with a 4.3% CAGR and a valuation of US$ 3,103.4 million by 2033.

The region's growth is backed by high demand in the United States, coupled with the country’s favorable healthcare reimbursement policies.

Governments in North America often extend support via managed care plans and comprehensive healthcare support. Spurred by this, the demand for 99Mo is considerably high in North America. Canada is likely to account for a 6.4% CAGR and a valuation of US$ 355 million by 2033.

Europe Improved Healthcare Facilities Creates a Favorable Molybdenum-99 Market Outlook

Europe, too has emerged as a lucrative market for molybdenum-99. Between 2023 and 2033, the Europe market is forecast to exhibit steady growth. The rising demand from countries such as Germany, the United Kingdom, France, and Spain has been crucial in enabling growth in the Europe market.

United Kingdom Market Outlook

Besides favorable reimbursement policies, a focus on innovations to offer better healthcare facilities is driving growth in the United Kingdom. The market is aided by the presence of sophisticated healthcare infrastructure. The market is likely to be worth US$ 245.5 million and has a CAGR of 3.8% by 2033 as a result of steadily expanding demand from hospitals and diagnostic centers.

Germany Market Outlook

By 2033, Germany is likely to provide the most to Europe's total value-$407 million. The demand in the nation is extremely strong, and the trend is not expected to change in the upcoming years. Also, the presence of several top businesses supports the growth being experienced in the area.

Advanced Healthcare Technologies: Boon to Asia Pacific Molybdenum-99 Demand

China’s rising investment in healthcare development and strengthening research and development initiatives bode well for the market. Penetration of advanced healthcare technologies is rising, which works in favour of growth in the region. However, a lack of trained professionals and poor healthcare facilities have been creating bottlenecks to growth in certain under-developed pockets.

The use of private healthcare is increasing in countries such as India. In fact, studies report remarkable growth in this sector since 2000. Additionally, insurance support extended by various government and non-government providers has been supporting patients and their families, encouraging them to spend on advanced healthcare.

In South Asia, too, hospitals have emerged as a more attractive segment than diagnostic centers. Demand from countries such as India, Thailand, Indonesia, and Malaysia supports the expansion of the market in the region.

Category Analysis

Segment Isotopic Application
Top Segment Gamma Camera
Market CAGR (2017 to 2022) 4.1%
Market CAGR (2023 to 2033) 3.1%
Segment End Users
Top Segment Hospitals
Market CAGR (2017 to 2022) 5.3%
Market CAGR (2023 to 2033) 4.9%
  • Based on Isotopic Application: Due to the growing usage of gamma cameras for medical imaging, such as for the diagnosis of cancer, cardiovascular diseases, and neurological disorders, this segment is anticipated to take the lead by 2033.
  • Based on End User: hospitals account for the leading share in the global market. Hospitals remain dominant, especially due to the rising healthcare spending recorded across the world.
    • It is also true that clinical and technological advances contribute to demand witnessed from hospitals and diagnostic centers alike.
    • New government administrations are pushing for affordable healthcare. This move has been of incredible importance for the market players.
    • The focus on making cancer treatment more affordable is expected to fuel demand from both end-use segments in the forthcoming years.

Competitive Analysis

Key Players in the Molybdenum-99 Industry Seek to Achieve High Investing Capacities

The need for technologies to create Mo-99 in an efficient and secure manner is increasing, along with the demand for the substance. To address this demand, businesses in the Mo-99 production technology market are creating cutting-edge methods and procedures. To lower production costs and boost safety, businesses are also creating new technologies and procedures.

The molybdenum market continues to be consolidated. Tier 1 players make up the bulk of the share. These businesses are at the forefront of numerous clinical studies that have been published in the market since they have higher investing capacities.

Mid-level players, too, are witnessing scope for expansion. In the coming years, the market is likely to see an immense focus on strengthening portfolios among the companies. Besides this, many of them also focus on the expansion of their footprint worldwide.

The key intent behind their strategies is to gain a competitive advantage. It is, therefore, a little surprising to witness investment towards research and development activities. Also, strategic collaborations are likely to become more common in the near future.

  • GE Healthcare signed an agreement with HealthTrust to supply radiopharmaceuticals in March 2017. It is, therefore, evidence that the company is focusing on boosting its supply via partnership agreements.
  • Curium Pharmaceuticals meanwhile acquired MAP Medical Technologies Oy, which is a radiopharmaceuticals company, in December 2019. The company intends to expand its footprint via this acquisition.

Key players

  • IBA
  • Sumitomo Corporation
  • Advanced Cyclotron Systems, Inc.
  • Siemens Healthineers

Key Segments

By Isotopic Application:

  • SPECT
  • Gamma Camera

By End User:

  • Hospitals
  • Diagnostic Centers

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Frequently Asked Questions

How Big is the Molybdenum-99 Market?

The Molybdenum-99 Market value reaches US$ 4.48 billion in 2023.

What are the Projected Dimensions of the Molybdenum-99 Market by 2033?

The Molybdenum-99 Market is anticipated to surpass US$ 7.28 billion by 2033, recording a CAGR of 5%.

Which is the Top Trend in the Molybdenum-99 Market?

The demand for molybdenum-99-based medical imaging methods is the main trend in the molybdenum-99 market.

Which Region Holds High Lucrativeness for Airbag Control Unit Sensors?

The Molybdenum-99 Market discovers profitable prospects within Asia Pacific.

Who is the Key Molybdenum-99 Market Players?

Key Molybdenum-99 Market players are Mallinckrodt, Nordian, IsoRay.

Table of Content

1. Executive Summary | Molybdenum-99 Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023 to 2033

        5.3.1. Production by Highly Enriched Uranium

        5.3.2. Production by Non-Highly Enriched Uranium

    5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033

        6.3.1. Medical

        6.3.2. Scientific Research

    6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. South Asia

        7.3.5. East Asia

        7.3.6. Oceania

        7.3.7. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. The USA

            8.2.1.2. Canada

        8.2.2. By Type

        8.2.3. By Application

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Type

        8.3.3. By Application

    8.4. Key Takeaways

9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Type

        9.2.3. By Application

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Type

        9.3.3. By Application

    9.4. Key Takeaways

10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. United Kingdom

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Europe

        10.2.2. By Type

        10.2.3. By Application

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Type

        10.3.3. By Application

    10.4. Key Takeaways

11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. India

            11.2.1.2. Malaysia

            11.2.1.3. Singapore

            11.2.1.4. Thailand

            11.2.1.5. Rest of South Asia

        11.2.2. By Type

        11.2.3. By Application

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Type

        11.3.3. By Application

    11.4. Key Takeaways

12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

        12.2.2. By Type

        12.2.3. By Application

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Type

        12.3.3. By Application

    12.4. Key Takeaways

13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. Australia

            13.2.1.2. New Zealand

        13.2.2. By Type

        13.2.3. By Application

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Type

        13.3.3. By Application

    13.4. Key Takeaways

14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Type

        14.2.3. By Application

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Type

        14.3.3. By Application

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Type

            15.1.2.2. By Application

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Type

            15.2.2.2. By Application

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Type

            15.3.2.2. By Application

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Type

            15.4.2.2. By Application

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Type

            15.5.2.2. By Application

    15.6. United Kingdom

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Type

            15.6.2.2. By Application

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Type

            15.7.2.2. By Application

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Type

            15.8.2.2. By Application

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Type

            15.9.2.2. By Application

    15.10. India

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Type

            15.10.2.2. By Application

    15.11. Malaysia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Type

            15.11.2.2. By Application

    15.12. Singapore

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Type

            15.12.2.2. By Application

    15.13. Thailand

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Type

            15.13.2.2. By Application

    15.14. China

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Type

            15.14.2.2. By Application

    15.15. Japan

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Type

            15.15.2.2. By Application

    15.16. South Korea

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Type

            15.16.2.2. By Application

    15.17. Australia

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Type

            15.17.2.2. By Application

    15.18. New Zealand

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Type

            15.18.2.2. By Application

    15.19. GCC Countries

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Type

            15.19.2.2. By Application

    15.20. South Africa

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2022

            15.20.2.1. By Type

            15.20.2.2. By Application

    15.21. Israel

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2022

            15.21.2.1. By Type

            15.21.2.2. By Application

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Type

        16.3.3. By Application

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Curium Company

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Eckert & Ziegler Holding Company

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Shine Medical Technologies

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. NTP Radioisotopes SOC Ltd.

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. North Star Medical Radioisotopes LLC

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. JSC Isotope

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. ANSTO

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. Lantheus Medical Imaging Inc.

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. IRE ELIT

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. Niowave Inc.

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Recommendations

Chemicals & Materials

Molybdenum Market

November 2017

REP-GB-5643

January 2023

333 pages

Explore Healthcare Insights

View Reports